Ex vivo MRI evaluation of breast tumors: A novel tool for verifying resection of nonpalpable only MRI detected lesions

Roberto Agresti, Giovanna Trecate, Cristina Ferraris, Barbara Valeri, Ilaria Maugeri, Cristina Pellitteri, Gabriele Martelli, Silvana Migliavacca, Maria Luisa Carcangiu, Silvia Bohm, Lorenzo Maffioli, Daniele Vergnaghi, Pietro Panizza

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A fundamental question in surgery of only magnetic resonance imaging (MRI)-detected breast lesions is to ensure their removal when they are not palpable by clinical examination and surgical exploration. This is especially relevant in the case of small tumors, carcinoma in situ or lobular carcinoma. Thirty-nine patients were enrolled in the study, 21 patients with breast lesions detected by both conventional imaging and breast MRI (bMRI) and 18 patients with bMRI findings only. Preoperative bMRI allowed staging the disease and localizing the lesion. In the operating theater, contrast medium was injected 1 minute before skin incision. After removal, surgical specimens were submitted to ex vivo MRI, performed using a dedicated surface coil and Spair inversion recovery sequences for suppression of fat signal intensity. All MRI enhancing lesions were completely included within the surgical specimen and visualized by ex vivo MRI. In the first 21 patients, bMRI was able to visualize branching margins or satellite nodules around the core lesion, and allowed for better staging of the surrounding in situ carcinoma; in the last 18 patients, eight of whom were breast cancer type 1 susceptibility protein (BRCA) mutation carriers, bMRI identified 12 malignant tumors, otherwise undetectable, that were all visualized by ex vivo MRI. This is the first description of a procedure that re-enhances breast lesions within a surgical specimen, demonstrating the surgical removal of nonpalpable breast lesions diagnosed only with bMRI. This new strategy reproduces the morphology and the entire extension of the primary lesion on the specimen, with potentially better local surgical control, reducing additional unplanned surgery.

Original languageEnglish
Pages (from-to)659-663
Number of pages5
JournalBreast Journal
Volume19
Issue number6
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Breast
Magnetic Resonance Imaging
Breast Neoplasms
Carcinoma in Situ
BRCA1 Protein
Sequence Inversion
Lobular Carcinoma
Contrast Media
Neoplasms
Fats
Skin
Mutation

Keywords

  • breast cancer
  • magnetic resonance imaging
  • non-palpable breast lesions

ASJC Scopus subject areas

  • Internal Medicine
  • Oncology
  • Surgery

Cite this

Ex vivo MRI evaluation of breast tumors : A novel tool for verifying resection of nonpalpable only MRI detected lesions. / Agresti, Roberto; Trecate, Giovanna; Ferraris, Cristina; Valeri, Barbara; Maugeri, Ilaria; Pellitteri, Cristina; Martelli, Gabriele; Migliavacca, Silvana; Carcangiu, Maria Luisa; Bohm, Silvia; Maffioli, Lorenzo; Vergnaghi, Daniele; Panizza, Pietro.

In: Breast Journal, Vol. 19, No. 6, 11.2013, p. 659-663.

Research output: Contribution to journalArticle

Agresti, Roberto ; Trecate, Giovanna ; Ferraris, Cristina ; Valeri, Barbara ; Maugeri, Ilaria ; Pellitteri, Cristina ; Martelli, Gabriele ; Migliavacca, Silvana ; Carcangiu, Maria Luisa ; Bohm, Silvia ; Maffioli, Lorenzo ; Vergnaghi, Daniele ; Panizza, Pietro. / Ex vivo MRI evaluation of breast tumors : A novel tool for verifying resection of nonpalpable only MRI detected lesions. In: Breast Journal. 2013 ; Vol. 19, No. 6. pp. 659-663.
@article{741ad917ebd04dff915f2a40f4e0ebdf,
title = "Ex vivo MRI evaluation of breast tumors: A novel tool for verifying resection of nonpalpable only MRI detected lesions",
abstract = "A fundamental question in surgery of only magnetic resonance imaging (MRI)-detected breast lesions is to ensure their removal when they are not palpable by clinical examination and surgical exploration. This is especially relevant in the case of small tumors, carcinoma in situ or lobular carcinoma. Thirty-nine patients were enrolled in the study, 21 patients with breast lesions detected by both conventional imaging and breast MRI (bMRI) and 18 patients with bMRI findings only. Preoperative bMRI allowed staging the disease and localizing the lesion. In the operating theater, contrast medium was injected 1 minute before skin incision. After removal, surgical specimens were submitted to ex vivo MRI, performed using a dedicated surface coil and Spair inversion recovery sequences for suppression of fat signal intensity. All MRI enhancing lesions were completely included within the surgical specimen and visualized by ex vivo MRI. In the first 21 patients, bMRI was able to visualize branching margins or satellite nodules around the core lesion, and allowed for better staging of the surrounding in situ carcinoma; in the last 18 patients, eight of whom were breast cancer type 1 susceptibility protein (BRCA) mutation carriers, bMRI identified 12 malignant tumors, otherwise undetectable, that were all visualized by ex vivo MRI. This is the first description of a procedure that re-enhances breast lesions within a surgical specimen, demonstrating the surgical removal of nonpalpable breast lesions diagnosed only with bMRI. This new strategy reproduces the morphology and the entire extension of the primary lesion on the specimen, with potentially better local surgical control, reducing additional unplanned surgery.",
keywords = "breast cancer, magnetic resonance imaging, non-palpable breast lesions",
author = "Roberto Agresti and Giovanna Trecate and Cristina Ferraris and Barbara Valeri and Ilaria Maugeri and Cristina Pellitteri and Gabriele Martelli and Silvana Migliavacca and Carcangiu, {Maria Luisa} and Silvia Bohm and Lorenzo Maffioli and Daniele Vergnaghi and Pietro Panizza",
year = "2013",
month = "11",
doi = "10.1111/tbj.12183",
language = "English",
volume = "19",
pages = "659--663",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Ex vivo MRI evaluation of breast tumors

T2 - A novel tool for verifying resection of nonpalpable only MRI detected lesions

AU - Agresti, Roberto

AU - Trecate, Giovanna

AU - Ferraris, Cristina

AU - Valeri, Barbara

AU - Maugeri, Ilaria

AU - Pellitteri, Cristina

AU - Martelli, Gabriele

AU - Migliavacca, Silvana

AU - Carcangiu, Maria Luisa

AU - Bohm, Silvia

AU - Maffioli, Lorenzo

AU - Vergnaghi, Daniele

AU - Panizza, Pietro

PY - 2013/11

Y1 - 2013/11

N2 - A fundamental question in surgery of only magnetic resonance imaging (MRI)-detected breast lesions is to ensure their removal when they are not palpable by clinical examination and surgical exploration. This is especially relevant in the case of small tumors, carcinoma in situ or lobular carcinoma. Thirty-nine patients were enrolled in the study, 21 patients with breast lesions detected by both conventional imaging and breast MRI (bMRI) and 18 patients with bMRI findings only. Preoperative bMRI allowed staging the disease and localizing the lesion. In the operating theater, contrast medium was injected 1 minute before skin incision. After removal, surgical specimens were submitted to ex vivo MRI, performed using a dedicated surface coil and Spair inversion recovery sequences for suppression of fat signal intensity. All MRI enhancing lesions were completely included within the surgical specimen and visualized by ex vivo MRI. In the first 21 patients, bMRI was able to visualize branching margins or satellite nodules around the core lesion, and allowed for better staging of the surrounding in situ carcinoma; in the last 18 patients, eight of whom were breast cancer type 1 susceptibility protein (BRCA) mutation carriers, bMRI identified 12 malignant tumors, otherwise undetectable, that were all visualized by ex vivo MRI. This is the first description of a procedure that re-enhances breast lesions within a surgical specimen, demonstrating the surgical removal of nonpalpable breast lesions diagnosed only with bMRI. This new strategy reproduces the morphology and the entire extension of the primary lesion on the specimen, with potentially better local surgical control, reducing additional unplanned surgery.

AB - A fundamental question in surgery of only magnetic resonance imaging (MRI)-detected breast lesions is to ensure their removal when they are not palpable by clinical examination and surgical exploration. This is especially relevant in the case of small tumors, carcinoma in situ or lobular carcinoma. Thirty-nine patients were enrolled in the study, 21 patients with breast lesions detected by both conventional imaging and breast MRI (bMRI) and 18 patients with bMRI findings only. Preoperative bMRI allowed staging the disease and localizing the lesion. In the operating theater, contrast medium was injected 1 minute before skin incision. After removal, surgical specimens were submitted to ex vivo MRI, performed using a dedicated surface coil and Spair inversion recovery sequences for suppression of fat signal intensity. All MRI enhancing lesions were completely included within the surgical specimen and visualized by ex vivo MRI. In the first 21 patients, bMRI was able to visualize branching margins or satellite nodules around the core lesion, and allowed for better staging of the surrounding in situ carcinoma; in the last 18 patients, eight of whom were breast cancer type 1 susceptibility protein (BRCA) mutation carriers, bMRI identified 12 malignant tumors, otherwise undetectable, that were all visualized by ex vivo MRI. This is the first description of a procedure that re-enhances breast lesions within a surgical specimen, demonstrating the surgical removal of nonpalpable breast lesions diagnosed only with bMRI. This new strategy reproduces the morphology and the entire extension of the primary lesion on the specimen, with potentially better local surgical control, reducing additional unplanned surgery.

KW - breast cancer

KW - magnetic resonance imaging

KW - non-palpable breast lesions

UR - http://www.scopus.com/inward/record.url?scp=84886779367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886779367&partnerID=8YFLogxK

U2 - 10.1111/tbj.12183

DO - 10.1111/tbj.12183

M3 - Article

C2 - 24102850

AN - SCOPUS:84886779367

VL - 19

SP - 659

EP - 663

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 6

ER -